%2520(1).png)
As the cannabis industry continues to expand, 2024 is proving to be a pivotal year for the global legalization of cannabis, particularly in the medical realm. With countries worldwide revisiting their cannabis policies, the landscape is rapidly changing.
Germany continues to lead the charge in Europe with its ambitious plan to legalize both medical and recreational cannabis. This move is expected to ripple through neighboring countries, many of which are already expanding their medical cannabis programs. Meanwhile, countries like Portugal and the Netherlands are evolving their frameworks, offering more access to medical cannabis treatments.
In the U.S., while federal legalization remains elusive, individual states continue to push forward. States like New York and New Mexico have implemented legal cannabis frameworks that are expected to become major economic drivers. Canada continues to fine-tune its policies, ensuring a balance between consumer access and regulatory oversight.
Countries in Latin America, particularly Mexico and Colombia, are actively reconsidering cannabis regulations. Mexico is on the verge of creating one of the largest legal cannabis markets in the world, while Colombia continues to position itself as a major exporter of medical cannabis. These changes are reshaping the global cannabis supply chain.
Asia remains cautious regarding cannabis legalization, but there are signs of change. Thailand has taken bold steps by legalizing medical cannabis and allowing home cultivation. This move could set a precedent for other Asian countries to explore cannabis for medical purposes.
As more countries adopt medical cannabis laws, the global market is poised for exponential growth. With projections suggesting that the global cannabis industry could reach over $200 billion by 2030, the future of cannabis legalization looks promising for 2024 and beyond.
.svg)
.svg)
